What moved ALDEI.PA stock higher intraday today?

High trading volume — **13,014,939** shares versus avg **5,992,347** — drove ALDEI.PA stock moves, likely on speculative flows and attention to biotech catalysts rather than fresh earnings.

What is Meyka AI’s grade for ALDEI.PA stock and what it means?

Meyka AI rates ALDEI.PA **64.99/100 (B, HOLD)**. The grade weighs sector comparisons, growth, key metrics and consensus. It is informational and not financial advice.

What is the short-term price outlook for ALDEI.PA stock?

Meyka AI's forecast model projects **€0.040** in 12 months versus current **EUR 0.0265**, an implied upside of **50.94%**; forecasts are model-based projections and not guarantees.

Which risks should traders watch in ALDEI.PA stock?

Watch clinical trial outcomes, dilution risk from capital raises, and thin-market liquidity. Price swings can be large with limited bid depth, increasing execution risk.

EU Stocks

ALDEI.PA Deinove SA (EURONEXT) €0.0265 on 11 Feb 2026: Most-active stock with high volume

ByHuzaifa Zahoor February 11, 2026

ALDEI.PA stock is trading as one of the most active small-caps on EURONEXT intraday on 11 Feb 2026, changing hands at €0.0265 with 13,014,939 shares traded so far. Volume is more than double the average, driven by speculative flows and microcap liquidity. Investors watching biotechnology names should note Deinove SA (ALDEI.PA) shows a wide intraday range, a thin market cap of about €1.13 million, and negative earnings per share of -0.24, which links any price move to news or funding updates.